Author:
Gruber H. E.,Vuchinich M.,Marlow T. A.,Plent M. M.,Willis R. C.,Seegmiller J. E.,Bartley J.,Hanson J. W.,Zellweger H.
Reference5 articles.
1. Holland, M. J. C., A. M. DiLorenzo, J. Dancis, M. E. Balis, T. F. Yu, and R. P. Cox. Hypoxanthine phosphoribosyltransferase activity in intact fibroblasts from patients with X-linked hyperuricemia. J. Clin. Invest. 57: 1600–1605, 1976.
2. Dancis, J., L. C. Yip, R. P. Cox, S. Piomelli and M. E. Balis. Disparate enzyme activity in erythrocytes and leukocytes. J. Clin. Invest. 52: 2068–2074, 1973.
3. Emerson, B. T., and L. Thompson. The spectrum of hypoxanthineguanine phosphoribosyltransferase deficiency. Quart. J. Med. 42: 423–440, 1973.
4. Uitendaal, M. P., C.H.M.M., deBruyn, T. L. Oei, and P. Hosli. Molecular and tissue-specific heterogeneity in HPRT deficiency. Biochem. Genetics 16: 1187–1202, 1978.
5. Page, T., B. Bakay, E. Nissinen and W. Nyhan. Hypoxanthine guanine phosphoribosyltransferase variants: Correlation of clinical phenotype with enzyme activity. J. Inherit. Metab. Dis. 4: 203–206, 1981.